Sarepta Therapeutics, Inc. (SRPT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Sarepta Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.16x | 49.14x | -16.62x | -16.13x | -17.47x | -23.98x |
| P/B Ratio | 1.98x | 7.57x | 10.37x | 29.47x | 7.89x | 17.45x |
| P/S Ratio | 1.03x | 6.08x | 7.17x | 12.16x | 10.43x | 24.61x |
| Profitability | ||||||
| Gross Margin | 59.9% | 83.2% | 87.9% | 85.0% | 86.2% | 88.3% |
| Operating Margin | -29.9% | 11.5% | -21.5% | -57.5% | -65.5% | -104.5% |
| Net Margin | -32.5% | 12.4% | -43.1% | -75.4% | -59.7% | -102.6% |
| EBITDA Margin | -29.5% | 16.7% | -36.5% | -63.8% | -45.2% | -83.9% |
| Liquidity | ||||||
| Current Ratio | 2.32x | 4.20x | 3.95x | 4.13x | 5.75x | 5.97x |
| Quick Ratio | 1.48x | 3.18x | 3.45x | 3.80x | 5.34x | 5.42x |
| Leverage | ||||||
| Debt/Equity | 0.91x | 0.88x | 1.63x | 4.20x | 1.24x | 1.44x |
YoY = year-over-year change. Source: FMP..